Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04617548 · ClinicalTrials.gov registry record · Phase 1
tDCS and CO-OP in Chronic Stroke
A Phase 1 study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- Phase 1
- Development phase
- 8
- Enrollment target
NCT04617548: Completed Phase 1 study, sponsored by University of Missouri-Columbia.
NCT04617548 is a Phase 1 study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 8 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04617548, a Phase 1 study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
This project seeks to evaluate the acceptability feasibility, practicality feasibility, and preliminary effect of combining transcranial direct current stimulation (tDCS) and metacognitive strategy training (MCST) in individuals with chronic stroke.
Primary Outcome
A brief questionnaire to evaluate participant satisfaction regarding the intervention's acceptability, appropriateness, and feasibility
Interventions
- COMBINATION_PRODUCT tDCS and CO-OP Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2022-01-01 |
| Phase | Phase 1 |
What the finished NCT04617548 record still lists
NCT04617548 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (87% lower).
The record links to 0 conditions, and to 1 intervention - of which tDCS and CO-OP Group is the first listed.
NCT04617548 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04617548 about?
NCT04617548 is a clinical study titled "tDCS and CO-OP in Chronic Stroke". This project seeks to evaluate the acceptability feasibility, practicality feasibility, and preliminary effect of combining transcranial direct current stimulation (tDCS) and metacognitive strategy training (MCST) in individuals with chronic stroke.
What is the current status of trial NCT04617548?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 8 participants. The study started on 2020-01-01. Estimated completion is 2022-01-01.
What interventions are being tested in trial NCT04617548?
The interventions under investigation include: tDCS and CO-OP Group (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT04617548?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04617548's enrollment target sits among peer trials
8 1959th of 2000 higher than 29 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI